Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarti Pharmalabs Limited has submitted their response.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE flagged a significant increase in trading volume of Aarti Pharmalabs shares and asked the company to clarify on January 9, 2026. The company replied on January 12, 2026, stating that it has been regularly disclosing all required information to the stock exchanges under SEBI Listing Regulations. It confirmed there is no other undisclosed information or pending announcement that could explain the price or volume movement. The company attributed the increase in trading volume entirely to market-driven factors.
This is a routine surveillance clarification rather than any negative action. With no undisclosed information cited, investors should treat the volume spike as market activity without any fundamental trigger, so no immediate impact on the stock or shareholders is expected.